Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
  • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
  • C07D239/72—Quinazolines; Hydrogenated quinazolines
  • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
  • C07D239/88—Oxygen atoms
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
  • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
  • C07D239/72—Quinazolines; Hydrogenated quinazolines
  • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
  • C07D239/94—Nitrogen atoms

Definitions

• the present invention relates to a process for preparing a 4-aminoquinazoline compound from a quinazolin-4-one compound.
• the 4-aminoquinazoline compound is useful as an intermediate or a starting compound for preparing a pharmaceutically active compound or an agricultural chemical.
• the invention specifically relates to a process for preparing 6-halogeno-4-arylaminoquinazoline from 6-halogenoquinazolin-4-one.
• the invention further relates to a process for preparing 6-halogeno-4-chloroquinazoline from 6-halogenoquinazolin-4-one.
• the 6-halogeno-4-chloroquinazoline is employable as a starting compound for preparing the 6-halogeno-4-arylaminoquinazoline.
• JP-A-10-152477 describes a process for preparing a 4-arylaminoquinazoline compound from a quinazolin-4-one, which comprises the steps of chlorinating 4-iodoquinazolin-4-one using an excessive amount of oxalyl chloride to produce 6-iodo-4-chloroquinazoline (intermediate compound), concentrating the reaction product under reducing pressure to isolate the resulting product; reacting the 6-iodo-4-chloroquinazoline with 5-aminoindole to give 6-iodo-4-(5-indolylamino)quinazoline.
• the yield is not high.
• the intermediate compound i.e., 4-chloroquinazoline compound, shows no satisfactory stability in the presence of water and no satisfactory resistance to heat. Accordingly, the compound should be handled carefully.
• WO 96/09294 describes a process for preparing 6-halogeno-4-chloroquinazoline from 6-halogenoquinazolin-4-one which comprises reacting the 6-halogenoquinazolin-4-one with an excessive amount of phosphorus oxychloride.
• This process has problems in that a large amount of smelly phosphorus oxychloride should be used, yield of the reaction product (i.e., 6-halogeno-4-chloroquinazoline) is low, and a large amount of an organic solvent is necessarily employed for recovering the reaction product from an excessive amount of phosphorus oxychloride. Thus, complicated post-treating procedures are required.
• the present invention has an object to provide a simple process for preparing a 4-aminoquinazoline compound from a quinazolin-4-one compound.
• the invention specifically has an object to provide a process for preparing 6-halogeno-4-arylaminoquinazoline from 6-halogenoquinazolin-4-one.
• the invention further relates has an object to provide a process for preparing 6-halogeno-4-chloroquinazoline from 6-halogenoquinazolin-4-one.
• the 6-halogeno-4-chloroquinazoline is employable as a starting compound for preparing the 6-halogeno-4-arylaminoquinazoline.
• the present invention resides in a process for preparing a 4-aminoquinazoline compound having the formula (3): in which each of R 1 , R 2 , R 3 and R 4 independently represents a group not participating the below-mentioned reaction, or R 1 , R 2 , R 3 and R 4 are combined to form a ring, and each of R 5 and R 6 independently represents a hydrogen atom or a hydrocarbyl group which can have a substituent, which comprises:
• the invention further resides in the process wherein the quinazolin-4-one compound of formula (1) is 6-halogenoquinazolin-4-one of the following formula (4), the amine compound of formula (2) is arylamine of the following formula (5), and the 4-arylaminoquinazoline compound of formula (3) is 6-halogeno-4-arylaminoquinazoline of the following formula (6): in which X is a halogen atom, and Ar is an aryl group which can have a substituent.
• the invention furthermore resides in a process for preparing 6-halogeno-4-chloroquinazoline having the formula (7): in which X is a halogen atom, which comprises reacting 6-halogenoquinazolin-4-one having the formula (4): in which X has the same meaning as above, with a chlorinating agent in an organic solvent in the presence of an organic base.
• the quinazolin-4-one compound employed in the reaction of the invention as the starting compound is represented by the aforementioned formula (1).
• each of R 1 , R 2 , R 3 and R 4 a group that can have a substituent, and does not participate in the reactions of the first and second steps.
• the group is a hydrogen atom, an alkyl group having 1-12 carbon atoms, a cycloalkyl group having 1-12 carbon atoms, an aralkyl group having 7-15 carbon atoms, an aryl group having 6-14 carbon atoms, a halogen atom, an alkoxy group having 1-12 carbon atoms, an alkylthio group having 1-12 carbon atoms, an arylthio group having 6-14 carbon atoms, nitro, cyano, amino, carboxyl, ester groups, or amide.
• R 1 , R 2 , R 3 and R 4 can be combined with each other to form a ring.
• alkyl groups examples include methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, and decyl. These groups can be any of isomers.
• cycloalkyl groups examples include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl.
• aralkyl groups examples include benzyl, phenethyl, and phenylpropyl. These groups can be any of isomers.
• aryl groups examples include phenyl, p-tolyl, naphthyl, and anthryl. These groups can be any of isomers.
• halogen atoms include fluorine, chlorine, bromine, and iodine.
• alkoxy groups examples include methoxy, ethoxy, and propoxy. These groups can be any of isomers.
• alkylthio groups examples include methylthio, ethylthio, and propylthio. These groups can be any of isomers.
• arylthio groups examples include phenylthio, p-tolylthio, naphthylthio, and anthrylthio. These groups can be any of isomers.
• ester groups examples include methoxycarbonyl, ethoxycarbonyl, and propoxycarbonyl. These groups can be any of isomers.
• alkyl, cycloalkyl, aralkyl, aryl, alkoxy, alkylthio, arylthio, and amino may have a substituent.
• substituents include a substituent bonded via a carbon atom, a substituent bonded via an oxygen atom, a substituent bonded via a nitrogen atom, a substituent bonded via a sulfur atom, and a halogen atom.
• substituents bonded via a carbon atom include alkyl groups such as methyl, ethyl, propyl, butyl, pentyl, and hexyl; cycloalkyl groups such as cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl; alkenyl groups such as vinyl, allyl, propenyl, cyclopropenyl, cyclobutenyl, and cyclopentenyl; heterocyclic alkenyl groups such as pyrrolidyl, pyrrolyl, furyl, and thienyl; aryl groups such as phenyl, tolyl, xylyl, biphenylyl, naphthyl, anthryl, and phenanthryl; acyl groups (possibly be acetallized) such as formyl, acetyl, propionyl, acryloyl, pivaloyl, cycloal
• substituents bonded via an oxygen atom include hydroxyl; alkoxy groups such as methoxy, ethoxy, propoxy, butoxy, pentyloxy, hexyloxy, heptyloxy, benzyloxy, piperidyloxy, and pyranyloxy; and aryloxy groups such as phenoxy, toluyloxy, and naphthyloxy. These groups can be any of isomers.
• substituents bonded via a nitrogen atom include primary amino groups such as methylamino, ethylamino, butylamino, cyclohexylamino, phenylamino, and naphthylamino; secondary amino groups such as dimethylamino, diethylamino, dibutylamino, methylethylamino, methylbutylamino, and diphenylamino; heterocyclic amino groups such as morpholino, piperidino, piperazinyl, pyrazolidinyl, pyrrolidino, and indolyl; and imino. These groups can be any of isomers.
• substituents bonded via a sulfur atom include mercapto; thioalkoxy groups such as thiomethoxy, thioethoxy, and thiopropoxy; and thioaryloxy groups such as thiophenoxy, thiotoluyloxy, and thionaphthyloxy. These groups can be any of isomers.
• halogen atoms examples include fluorine, chlorine, bromine, and iodine.
• R 5 is a hydrogen atom or a hydrocarbyl group which can have a substituent.
• the hydrocarbyl groups include alkyl groups having 1-12 carbon atoms such as methyl, ethyl, propyl, butyl, pentyl, and hexyl; cycloalkyl groups such having 1-12 carbon atoms as cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl; aralkyl groups having 7-13 carbon atoms such as benzyl, phenethyl, and phenylpropyl; and aryl groups having 7-13 carbon atoms such as phenyl, tolyl, naphthyl, and anthryl. These groups can be any of isomers.
• the above-mentioned hydrocarbyl group can have a substituent.
• substituents are those described for R 1 , R 2 , R 3 and R 4 .
• the organic base used in the reaction of the first step can be an aliphatic amine such as trimethylamine, triethylamine, ethyldiisopropylamine, or tributylamine; an aromatic amine such as dimethylaniline or diethylaniline; or a heterocyclic amine such as pyridine, quinoline, pyrimidine, or 4-dimethylaminopyridine.
• Preferred is an aliphatic amine. More preferred is triethylamine.
• the organic base can be used singly or in combination.
• the organic base can be employed preferably in an amount of 0.8 to 2.5 moles, more preferably 1.0 to 1.5 moles, per one mole of the quinazolin-4-one compound.
• organic solvent employed in the reaction of the first step there are no specific limitations with respect to the organic solvent employed in the reaction of the first step, so far as the solvent does not participate in the reaction.
• examples are aliphatic hydrocarbons such as hexane, cyclohexane, and heptane; halogenated hydrocarbons such as chloroform and dichloroethane; aromatic hydrocarbons such as toluene, xylene, and mesitylene; halogenated aromatic hydrocarbons such as chlorobenzene; ethers such as diethyl ether, tetrahydrofuran, and dimethoxyethane; and amides such as N,N-dimethylformamide and 1,3-dimethylimidazolindione.
• aromatic hydrocarbons More preferred is toluene.
• the organic solvents can be employed singly or in combination. Further, the organic solvent can be placed in the reaction mixture while the reaction proceeds, if necessary.
• the amount of the organic solvent employed in the reaction depends on the homogeneity and stirring condition of the reaction mixture. It is preferred that the solvent is employed in an amount of 0.5 to 30 g (more preferably 1 to 10 g, most preferably 1 to 5 g) per one gram of the quinazolin-4-one compound.
• the chlorinating agent used in the reaction of the first step can be phosphorus oxychloride, phosphorus trichloride, phosphorus pentachloride, thionyl chloride, sulfuryl chloride, nitrosyl chloride, and chlorine molecule. Preferred is phosphorus oxychloride.
• the chlorinating agent can be used singly or in combination.
• the chlorinating agent is preferably employed in an amount of 0.9 to 7.0 moles, more preferably 1.0 to 5.0 moles, most preferably 1.0 to 2.5 moles per one mole of the quinazolin-4-one compound.
• the organic solvent employed in the reaction of the second step there are no specific limitations with respect to the organic solvent employed in the reaction of the second step, so far as the solvent does not participate in the reaction.
• the organic solvents include halogenated aliphatic hydrocarbons such as methylene chloride and chloroform; halogenated aromatic hydrocarbons such as chlorobenzene; nitrites such as acetonitrile and propionitrile; ketones such as acetone, methyl ethyl ketone, methyl isopropyl ketone, and methyl isobutyl ketone; and ethers such as diethyl ether, tetrahydrofuran, and dimethoxyethane.
• ketones More preferred is methyl ethyl ketone.
• the organic solvent can be used singly or in combination.
• the amount of the organic solvent employed in the reaction depends on the homogeneity and stirring condition of the reaction mixture. It is preferred that the solvent is employed in an amount of 0.1 to 10 mL (more preferably 0.5 to 5 mL) per one gram of the quinazolin-4-one compound.
• the amine compound used in the reaction of the second step of the invention is represented by the aforementioned formula (2).
• the reactions of the process of the invention can be performed, for instance, by a first step in which a quinazolin-4-one compound, an organic base, a chlorinating agent, and an organic solvent are mixed and stirred in an inert gas atmosphere, and a second step in which the resulting reaction liquid is further stirred after addition of an organic solvent and an amine compound.
• These reactions are preferably carried out at a temperature in the range of 10 to 150° C., more preferably 50 to 120° C., most preferably 40 to 100° C.
• the combination of the first and second steps can give the main product, i.e., hydrochloride of a 4-aminoquinazoline compound, which can be neutralized with a base (e.g., aqueous alkali metal hydroxide) to give a free 4-aminoquinazoline compound.
• a base e.g., aqueous alkali metal hydroxide
• the 4-aminoquinazoline compound produced in the second step can be isolated and purified by the conventional procedures such as filtration, extraction, concentration, distillation, recrystallization, and column chromatography.
• 6-halogeno-4-arylaminoquinazoline of formula (6) can be obtained by employing 6-halogenoquinazolin-4-one of formula (4) as the quinazolin-4-one compound and arylamine of formula (5) as the amine compound.
• X is a halogen atom (fluorine, chlorine, bromine, or iodine). Preferred is iodine.
• Ar in formulas (5) and (6) is an aryl group that can have a substituent. Examples of the aryl groups are carbon ring aromatic groups having 6-14 carbon atoms and heterocyclic aromatic groups such as phenyl, biphenylyl, naphthyl, anthryl, phenanthryl, pyridyl, quinolyl, pyrrolidyl, pyrrolyl, furyl, and thienyl.
• substituents are substituents bonded via carbon atom, substituents bonded via oxygen atom, substituents bonded via nitrogen atom, substituents bonded via sulfur atom, and halogen atoms. There are no limitations with respect to number and position of the substituent.
• 6-halogeno-4-arylaminoquinazoline hydrochloride is produced as a main product after the second step.
• This product can be converted to free 6-halogeno-4-arylaminoquinazoline by neutralization with a base (e.g., aqueous alkali metal hydroxide).
• a base e.g., aqueous alkali metal hydroxide.
• 6-halogenoquinazolin-4-one of formula (4) When 6-halogenoquinazolin-4-one of formula (4) is employed as the starting compound in the first step, the main reaction product, i.e., 6-halogeno-4-chloroquinazoline can be isolated before it is processed in the second step.
• 6-Halogeno-4-chloroquinazoline can be recovered as a crystalline product, for instance, by cooling the reaction liquid.
• the reaction liquid is stirred preferably at ⁇ 10-70° C., more preferably at 0-30° C., after addition of an organic solvent, whereby a crystalline product precipitates.
• the organic solvent can be halogenated aliphatic hydrocarbon such as methylene chloride or chloroform; halogenated aromatic hydrocarbon such as chlorobenzene; nitrites such as acetonitrile or propionitrile, ketone such as acetone, methyl ethyl ketone, methyl isopropyl ketone, or methyl isobutyl ketone; or ether such as diethyl ether, tetrahydrofuran, or dimethoxyethane.
• ketone More preferred is methyl ethyl ketone.
• the organic solvent can be used singly or in combination.
• the amount of the organic solvent depends on the homogeneity and stirring condition of the reaction mixture. It is preferred that the organic solvent is employed in an amount of 0.1 to 10 mL (more preferably 0.5 to 5 mL) per one gram of the 6-halogenoquinazolin-4-one.
• the crystalline product of 6-halogeno-4-chloroquinazoline can be further purified by stirring the product in aqueous alkali metal hydroxide to remove impurities (e.g., organic base hydrochloride).
• impurities e.g., organic base hydrochloride
• 6-Methyl-4-(3-chloro-4-methoxy)anilinoquinazoline had the following physical properties.
• the crystalline product was collected by filtration, washed with 30 mL of water, and dried under reduced pressure, to give 2.26 g (isolated yield: 84%, purity 99% in terms of area percentage determined by high performance liquid chromatography) of 6-iodo-4-benzylaminoquinazoline as a yellowish crystalline product.
• 6-Iodo-4-benzylaminoquinazoline had the following physical properties.
• Example I-3 The procedures of Example I-3 were repeated except for replacing benzylamine with 1.13 g (13.3 mmol) of piperidine, to give 2.26 g (isolated yield: 79%, purity 87% in terms of area percentage determined by high performance liquid chromatography) of 6-iodo-4-piperidinoquinazoline as a yellowish crystalline product.
• 6-Iodo-4-piperidinoquinazoline had the following physical properties.
• 6-Iodo-4-anilinoquinazoline had the following physical properties.
• Example II-1 The procedures of Example II-1 were repeated except that acetone was replaced with methyl isobutyl ketone and that 753 mg (8.1 mmol) of aniline was used, to give 1.90 g (isolated yield: 74%, purity 99% in terms of area percentage determined by high performance liquid chromatography) of 6-iodo-4-anilinoquinazoline.
• Example II-1 The procedures of Example II-1 were repeated except for replacing aniline with 1.39 g (8.8 mmol) of 3-chloro-4-methoxyaniline, to give 2.92 g (isolated yield: 96%, purity 96% in terms of area percentage determined by high performance liquid chromatography) of 6-iodo-4-(3-chloro-4-methoxy)anilinoquinazoline as a yellowish crystalline product.
• 6-Iodo-4-(3-chloro-4-methoxy)anilinoquinazoline had the following physical properties.
• Example II-3 The procedures of Example II-3 were repeated except that acetone was replaced with methyl isobutyl ketone and that 1.28 g (8.1 mmol) of 3-chloro-4-methoxyaniline was used, to give 2.55 g (isolated yield: 84%, purity 99% in terms of area percentage determined by high performance liquid chromatography) of 6-iodo-4-(3-chloro-4-methoxy)anilinoquinazoline.
• Example II-1 The procedures of Example II-1 were repeated except that acetone was replaced with methyl isobutyl ketone and that aniline was replaced with 1.18 g (8.1 mmol) of 3-chloro-4-fluoroaniline, to give 2.45 g (isolated yield: 83%, purity 99% in terms of area percentage determined by high performance liquid chromatography) of 6-iodo-4-(3-chloro-4-fluoro)anilinoquinazoline as a pale yellow crystalline product.
• 6-Iodo-4-(3-chloro-4-fluoro)anilinoquinazoline had the following physical properties.
• the crystalline product was collected by filtration, washed with 500 mL of water and 20 mL of acetonitrile, and dried under reduced pressure, to give 18.0 g (isolated yield: 98%, purity 100% in terms of area percentage determined by high performance liquid chromatography) of 6-iodo-4-[3-chloro-4-(3-fluorobenzyloxy)anilino]quinazoline as a yellowish crystalline product.
• 6-Iodo-4-[3-chloro-4-(3-fluorobenzyloxy)anilino]-quinazoline had the following physical properties.
• the crystalline product was collected by filtration, washed with 50 mL of water and 5 mL of acetonitrile, and dried under reduced pressure, to give 2.28 g (isolated yield: 71%, purity 89% in terms of area percentage determined by high performance liquid chromatography) of 4-(3-chloro-4-fluoroanilino)-6-methoxy-7-(3-morpholinopropoxy)quinazoline as a sallowish crystalline product.
• 6-halogeno-4-chloroquinazoline was reacted with methanol to give 6-halogeno-4-methoxyquinazoline quantitatively, which was then analyzed by high performance liquid chromatography.
• 6-Iodo-4-chloroquinazoline had the following physical properties.
• Example IV-2 The procedures of Example IV-2 were repeated except that 1.80 g (11.8 mmol) of phosphorus oxychloride was used and that 1.19 g (11.8 mmol) of triethylamine was used. There was produced 2.11 g (reaction yield: 99%) of 6-iodo-4-chloroquinazoline.
• Example IV-2 The procedures of Example IV-2 were repeated except that 2.48 g (16.2 mmol) of phosphorus oxychloride was used and that 1.64 g (16.2 mmol) of triethylamine was used. There was produced 2.14 g (reaction yield: 100%) of 6-iodo-4-chloroquinazoline.
• Example IV-2 The procedures of Example IV-2 were repeated except that the reaction temperature was changed to 55° C. There was produced 2.05 g (reaction yield: 96%) of 6-iodo-4-chloroquinazoline.
• Example IV-2 The procedures of Example IV-2 were repeated except that the reaction temperature was changed to 95° C. There was produced 2.09 g (reaction yield: 98%) of 6-iodo-4-chloroquinazoline.
• Example IV-4 The procedures of Example IV-4 were repeated except for replacing triethylamine with 1.96 g (16.2 mmol) of N,N-dimethylaniline. There was produced 1.92 g (reaction yield: 90%) of 6-iodo-4-chloroquinazoline.
• Example IV-4 The procedures of Example IV-4 were repeated except for replacing triethylamine with 1.28 g (16.2 mmol) of pyridine. There was produced 1.96 g (reaction yield: 92%) of 6-iodo-4-chloroquinazoline.
• Example IV-9 The procedures of Example IV-9 were repeated except for replacing acetone with methyl ethyl ketone. There was produced 44.9 g (isolated yield: 84%) of 6-iodo-4-chloroquinazoline.
• Example IV-9 The procedures of Example IV-9 were repeated except for replacing acetone with methyl isopropyl ketone. There was produced 48.6 g (isolated yield: 91%) of 6-iodo-4-chloroquinazoline.
• Example IV-9 The procedures of Example IV-9 were repeated except for replacing acetone with acetonitrile. There was produced 48.1 g (isolated yield: 90%) of 6-iodo-4-chloroquinazoline.
• Example IV-9 The procedures of Example IV-9 were repeated except for replacing acetone with chloroform. There was produced 48.1 g (isolated yield: 90%) of 6-iodo-4-chloroquinazoline.
• Example IV-9 The procedures of Example IV-9 were repeated except for replacing acetone with tetrahydrofuran. There was produced 47.6 g (isolated yield: 89%) of 6-iodo-4-chloroquinazoline.
• Example IV-1 The procedures of Example IV-1 were repeated except for replacing toluene with chlorobenzene. There was produced 48.1 g (isolated yield: 90%) of 6-iodo-4-chloroquinazoline.
• Example IV-1 The procedures of Example IV-1 were repeated except that the stirring temperature after completion of the reaction was changed from 0° C. to 25° C. There was produced 45.4 g (isolated yield: 85%) of 6-iodo-4-chloroquinazoline.
• Example IV-10 The procedures of Example IV-10 were repeated except that the stirring temperature after completion of the reaction was changed from 0° C. to 25° C. There was produced 44.9 g (isolated yield: 84%) of 6-iodo-4-chloroquinazoline.
• Example IV-9 The procedures of Example IV-9 were repeated except that acetone was replaced with methyl isopropyl ketone and that the stirring temperature after completion of reaction was changed from 0° C. to 25° C. There was produced 47.0 g (isolated yield: 88%) of 6-iodo-4-chloroquinazoline.
• Example IV-9 The procedures of Example IV-9 were repeated except that acetone was replaced with methyl isobutyl ketone and that the stirring temperature after completion of reaction was changed from 0° C. to 25° C. There was produced 44.9 g (isolated yield: 84%) of 6-iodo-4-chloroquinazoline.
• 4-aminoquinazoline compounds can be produced from quinazolin-4-one compounds by simple procedures.
• 6-halogeno-4-arylaminoquinazoline can be produced from 6-halogenoquinazolin-4-one by simple procedures.
• the invention provides processes for producing 6-iodo-4-[3-chloro-4-(3-fluorobenzyloxy)anilino]quinazoline, 6,7-bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline, and 4-(3-chloro-4-fluoroanilino)-6-methoxy-7-(3-morpholinopropoxy)quinazoline.
• These compounds are of value as intermediate compounds for preparing pharmaceuticals showing excellent pharmacological functions.

Priority Applications (2)

Applications Claiming Priority (9)

Related Child Applications (2)

Publications (1)

Family

ID=27739271

Family Applications (3)

Family Applications After (2)

Country Status (6)

Cited By (8)

Families Citing this family (8)

Citations (3)

Family Cites Families (10)

• 2003
  • 2003-02-06 WO PCT/JP2003/001254 patent/WO2003066602A1/ja active Application Filing
  • 2003-02-06 EP EP03703218A patent/EP1481971B1/en not_active Expired - Lifetime
  • 2003-02-06 AU AU2003207291A patent/AU2003207291A1/en not_active Abandoned
  • 2003-02-06 JP JP2003565976A patent/JP4389205B2/ja not_active Expired - Fee Related
  • 2003-02-06 AT AT03703218T patent/ATE533750T1/de active
  • 2003-02-06 US US10/503,664 patent/US20050130995A1/en not_active Abandoned
• 2008
  • 2008-03-19 US US12/051,605 patent/US20080177069A1/en not_active Abandoned
• 2009
  • 2009-03-10 US US12/400,895 patent/US8318932B2/en not_active Expired - Fee Related

Patent Citations (3)

Also Published As

Similar Documents

Legal Events